Agnes Bacusca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agnes Bacusca has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Adorata Elena Coman
“Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania
6 shared publications - Elena Popa
“Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania
5 shared publications - Monica Iuliana Ungureanu
Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania
5 shared publications - Antoneta Dacia Petroaie
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
4 shared publications - Mihaela Manole
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
4 shared publications - Ana Maria Slanina
“Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8706
From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review
Cardiometabolic prevention in primary care draws on a growing number of risk markers, yet a marker’s capacity to predict risk is often conflated with its capacity to change management. This narrative review proposes a semi-quantitative clinical actionability framework that takes the marker–context–action use case as its unit of appraisal and assigns ordinal scores (0–3) to seven domains: measurement readiness, prognostic validity, decision-relevant information, therapeutic linkage, clinical-utility evidence, harms and burden, and transportability and equity. Gating rules prevent prognostic strength alone from determining the tier. Applied by the authors to 19 use cases, the framework provisionally assigned five to Tier A (routine actionability): low-density lipoprotein cholesterol, blood pressure, type 2 diabetes detection, kidney function with albuminuria in diabetes or hypertension, and familial hypercholesterolaemia case-finding. Nine were assigned to Tier B (selective actionability), including the coronary artery calcium, apolipoprotein B, lipoprotein(a), natriuretic peptide and ankle–brachial index use cases, three to Tier C and two to Tier D. Most assignments depended on one-point differences in therapeutic linkage or clinical-utility scores. Tiers describe evaluated use cases, not intrinsic marker properties; the framework has not been validated. It implies that closing implementation gaps in Tier A use cases should generally precede the introduction of newer markers.
- 7 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8706
Open AccessFrom Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review
Cardiometabolic prevention in primary care draws on a growing number of risk markers, yet a marker’s capacity to predict risk is often conflated with its capacity to change management. This narrative review proposes a semi-quantitative clinical actionability framework that takes the marker–context–action use case as its unit of appraisal and assigns ordinal scores (0–3) to seven domains: measurement readiness, prognostic validity, decision-relevant information, therapeutic linkage, clinical-utility evidence, harms and burden, and transportability and equity. Gating rules prevent prognostic strength alone from determining the tier. Applied by the authors to 19 use cases, the framework provisionally assigned five to Tier A (routine actionability): low-density lipoprotein cholesterol, blood pressure, type 2 diabetes detection, kidney function with albuminuria in diabetes or hypertension, and familial hypercholesterolaemia case-finding. Nine were assigned to Tier B (selective actionability), including the coronary artery calcium, apolipoprotein B, lipoprotein(a), natriuretic peptide and ankle–brachial index use cases, three to Tier C and two to Tier D. Most assignments depended on one-point differences in therapeutic linkage or clinical-utility scores. Tiers describe evaluated use cases, not intrinsic marker properties; the framework has not been validated. It implies that closing implementation gaps in Tier A use cases should generally precede the introduction of newer markers.
- Open Access
- 27 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3635
Correlates of Health Satisfaction in a Web-Based Sample Enriched for Self-Reported Polycystic Ovary Syndrome: An Exploratory Cross-Sectional Study
Background/Objectives: Polycystic ovary syndrome (PCOS), named polyendocrine metabolic ovarian syndrome by a 2026 global consensus, combines metabolic, dermatological and psychological features. We examined which clinical, anthropometric and symptom-related characteristics were associated with health satisfaction in a web-based sample enriched for self-reported PCOS. Methods: Cross-sectional web-based survey using a Romanian-language questionnaire (October–November 2023). Of 212 submissions retained after integrity screening, 159 (75.0%) reported a previous diagnosis of PCOS. Health satisfaction (study-specific five-point item) was analysed with proportional-odds ordinal regression including seven covariates, irrespective of diagnostic status (n = 194). Sensitivity analyses restricted the model to respondents reporting a diagnosis, adjusted for diagnostic status or sociodemographic characteristics and retained all submissions. Results: Lower health satisfaction was associated with higher body mass index (OR 0.92 per kg/m2; 95% CI 0.87–0.97), self-reported hirsutism (OR 0.43; 95% CI 0.24–0.76) and reported anxiety (OR 0.49; 95% CI 0.28–0.87; reference group mostly “do not know/no answer”). Estimates changed little after these adjustments or with all submissions; among respondents reporting a diagnosis (n = 145), the estimates for self-reported hirsutism and reported anxiety were attenuated and imprecise. Age, menstrual irregularity, infertility diagnosis and dysmenorrhea severity showed no statistically detectable association. Conclusions: These exploratory, mutually adjusted associations involve higher body mass index, self-reported hirsutism and endorsement of the questionnaire’s anxiety option; the last reflects a response contrast, not clinically assessed anxiety. They warrant confirmation in clinically characterised cohorts using validated instruments.
- 27 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3635
Open AccessCorrelates of Health Satisfaction in a Web-Based Sample Enriched for Self-Reported Polycystic Ovary Syndrome: An Exploratory Cross-Sectional Study
Background/Objectives: Polycystic ovary syndrome (PCOS), named polyendocrine metabolic ovarian syndrome by a 2026 global consensus, combines metabolic, dermatological and psychological features. We examined which clinical, anthropometric and symptom-related characteristics were associated with health satisfaction in a web-based sample enriched for self-reported PCOS. Methods: Cross-sectional web-based survey using a Romanian-language questionnaire (October–November 2023). Of 212 submissions retained after integrity screening, 159 (75.0%) reported a previous diagnosis of PCOS. Health satisfaction (study-specific five-point item) was analysed with proportional-odds ordinal regression including seven covariates, irrespective of diagnostic status (n = 194). Sensitivity analyses restricted the model to respondents reporting a diagnosis, adjusted for diagnostic status or sociodemographic characteristics and retained all submissions. Results: Lower health satisfaction was associated with higher body mass index (OR 0.92 per kg/m2; 95% CI 0.87–0.97), self-reported hirsutism (OR 0.43; 95% CI 0.24–0.76) and reported anxiety (OR 0.49; 95% CI 0.28–0.87; reference group mostly “do not know/no answer”). Estimates changed little after these adjustments or with all submissions; among respondents reporting a diagnosis (n = 145), the estimates for self-reported hirsutism and reported anxiety were attenuated and imprecise. Age, menstrual irregularity, infertility diagnosis and dysmenorrhea severity showed no statistically detectable association. Conclusions: These exploratory, mutually adjusted associations involve higher body mass index, self-reported hirsutism and endorsement of the questionnaire’s anxiety option; the last reflects a response contrast, not clinically assessed anxiety. They warrant confirmation in clinically characterised cohorts using validated instruments.
- Open Access
- 26 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1769
Brain Death and Organ Donation in Romania: A Nationwide Survey of Intensivists’ Perceptions and Clinical Practices
Background/Objectives: A persistent mismatch between organ supply and transplant demand affects healthcare systems worldwide, particularly in underdeveloped and transitional systems. Intensive care units (ICUs) represent the primary setting for donor identification following brain death, placing intensive care physicians at the center of organ donation pathways. This nationwide cross-sectional survey aimed to evaluate Romanian intensivists’ knowledge, attitudes, and reported clinical practices regarding brain death determination, communication with families, and system-level barriers to organ donation, to identify modifiable factors relevant to transplant policy development. Methods: A prospective, nationwide, questionnaire-based survey was conducted among intensive care physicians in Romania. The structured questionnaire explored their knowledge and attitudes regarding brain death, communication with families, involvement in donation processes, ethical perceptions, and views on the organization of the transplant system. The survey was distributed through the Romanian Society of Anesthesia and Intensive Care, and descriptive exploratory analyses were performed. Results: A total of 117 ICU physicians participated (mean age 41.0 ± 9.9 years). Although 84.6% agreed with the current brain death diagnostic criteria, and 83% considered the protocol sufficiently clear. The mean number of brain-dead patients managed annually was 8.25 ± 12.90. 69.3% of respondents perceived communication competencies as insufficient. 77.8% considered family consent decisive in donation decisions, while 87% supported the establishment of a national donor registry and 77% favored a donor card system. Organ procurement was reported as a priority in only 38.5% of ICUs. Institutional prioritization of organ procurement and structured training was inconsistent. Conclusions: This nationwide survey identifies key educational, organizational, and systemic barriers limiting organ donation performance in Romania. Targeted training, improved communication strategies, integration of donation pathways into routine intensive care practice, and the adoption of national consent instruments represent essential clinical and policy priorities for low-performing transplant systems.
- 26 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1769
Open AccessBrain Death and Organ Donation in Romania: A Nationwide Survey of Intensivists’ Perceptions and Clinical Practices
Background/Objectives: A persistent mismatch between organ supply and transplant demand affects healthcare systems worldwide, particularly in underdeveloped and transitional systems. Intensive care units (ICUs) represent the primary setting for donor identification following brain death, placing intensive care physicians at the center of organ donation pathways. This nationwide cross-sectional survey aimed to evaluate Romanian intensivists’ knowledge, attitudes, and reported clinical practices regarding brain death determination, communication with families, and system-level barriers to organ donation, to identify modifiable factors relevant to transplant policy development. Methods: A prospective, nationwide, questionnaire-based survey was conducted among intensive care physicians in Romania. The structured questionnaire explored their knowledge and attitudes regarding brain death, communication with families, involvement in donation processes, ethical perceptions, and views on the organization of the transplant system. The survey was distributed through the Romanian Society of Anesthesia and Intensive Care, and descriptive exploratory analyses were performed. Results: A total of 117 ICU physicians participated (mean age 41.0 ± 9.9 years). Although 84.6% agreed with the current brain death diagnostic criteria, and 83% considered the protocol sufficiently clear. The mean number of brain-dead patients managed annually was 8.25 ± 12.90. 69.3% of respondents perceived communication competencies as insufficient. 77.8% considered family consent decisive in donation decisions, while 87% supported the establishment of a national donor registry and 77% favored a donor card system. Organ procurement was reported as a priority in only 38.5% of ICUs. Institutional prioritization of organ procurement and structured training was inconsistent. Conclusions: This nationwide survey identifies key educational, organizational, and systemic barriers limiting organ donation performance in Romania. Targeted training, improved communication strategies, integration of donation pathways into routine intensive care practice, and the adoption of national consent instruments represent essential clinical and policy priorities for low-performing transplant systems.
- Open Access
- 25 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11383
Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.
- 25 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11383
Open AccessDysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.
- Top Cited PapersOpen Access
- 26 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 5102
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Review
Cognitive dysfunction represents one of the most persistent and disabling features of Long COVID, yet its molecular underpinnings remain incompletely understood. This narrative review synthesizes current evidence on the pathophysiological mechanisms linking SARS-CoV-2 infection to long-term neurocognitive sequelae. Key processes include persistent neuroinflammation, blood–brain barrier (BBB) disruption, endothelial dysfunction, immune dysregulation, and neuroendocrine imbalance. Microglial activation and cytokine release (e.g., IL-6, TNF-α) promote synaptic dysfunction and neuronal injury, while activation of inflammasomes such as NLRP3 amplifies CNS inflammation. Vascular abnormalities, including microthrombosis and BBB leakage, facilitate the infiltration of peripheral immune cells and neurotoxic mediators. Hypothalamic–pituitary–adrenal axis dysfunction and reduced vagal tone further exacerbate systemic inflammation and autonomic imbalance. Biomarkers such as GFAP, NFL, IL-6, and S100B have been associated with both neuroinflammation and cognitive symptoms. Notably, transcriptomic signatures in Long COVID overlap with those observed in Alzheimer’s disease, highlighting shared pathways involving tau dysregulation, oxidative stress, and glial reactivity. Understanding these mechanisms is critical for identifying at-risk individuals and developing targeted therapeutic strategies. This review underscores the need for longitudinal research and integrative biomarker analysis to elucidate the molecular trajectory of cognitive impairment in Long COVID.
- 26 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 5102
Top Cited PapersOpen AccessThe Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Review
Cognitive dysfunction represents one of the most persistent and disabling features of Long COVID, yet its molecular underpinnings remain incompletely understood. This narrative review synthesizes current evidence on the pathophysiological mechanisms linking SARS-CoV-2 infection to long-term neurocognitive sequelae. Key processes include persistent neuroinflammation, blood–brain barrier (BBB) disruption, endothelial dysfunction, immune dysregulation, and neuroendocrine imbalance. Microglial activation and cytokine release (e.g., IL-6, TNF-α) promote synaptic dysfunction and neuronal injury, while activation of inflammasomes such as NLRP3 amplifies CNS inflammation. Vascular abnormalities, including microthrombosis and BBB leakage, facilitate the infiltration of peripheral immune cells and neurotoxic mediators. Hypothalamic–pituitary–adrenal axis dysfunction and reduced vagal tone further exacerbate systemic inflammation and autonomic imbalance. Biomarkers such as GFAP, NFL, IL-6, and S100B have been associated with both neuroinflammation and cognitive symptoms. Notably, transcriptomic signatures in Long COVID overlap with those observed in Alzheimer’s disease, highlighting shared pathways involving tau dysregulation, oxidative stress, and glial reactivity. Understanding these mechanisms is critical for identifying at-risk individuals and developing targeted therapeutic strategies. This review underscores the need for longitudinal research and integrative biomarker analysis to elucidate the molecular trajectory of cognitive impairment in Long COVID.
- Open Access
- 9 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31331
The Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults
In Romania, as in other parts of the world, the family doctor is the first to make contact with a healthy patient and is also the first to notice even the smallest pathological changes. In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the patient's communication with the family doctor became even closer and some behavioral changes could be easily noticed. To assess the symptoms of anxiety and depression in the Romanian population using social media platforms in the context of the COVID-19 pandemic. We conducted an anonymous, web-based cross-sectional survey consisting of 31 questions related to general characteristics (age, gender, education, inhabitancy, residence, smoking status, and alcohol consumption) and adapted GAD-7 (7-item General Anxiety Disorders questionnaire) and PHQ-9 (9-item Patient Health Questionnaire). This questionnaire was sent to volunteers in an electronic format through a social network (Facebook, Twitter). The data collected were statistically processed using IBM SPSS v25.0 (IBM Corp., Armonk, NY). The inclusion criteria were age over 18 years and no history of chronic disease. The exclusion criteria consisted of the absence of a mental illness diagnosis. From the 1254 respondents, 1232 cases were selected for statistical analysis after applying the exclusion criteria. The mean age was 35.94 (SD = 11.4, 95%CI=10.9-11.9) with a minimum of 18 years and a maximum of 97 years. Eighty-four point nine percent (84.9%; N=1046) of all study participants are female and 79.13% (N= 975) live in the urban area. A total of 188 (15.25%) were diagnosed with COVID-19 of which 31 (16.66%) were male and 157 (15%) were female. N=170 (13.8%) reported moderate symptoms of anxiety during the last two weeks before the survey while N=96 (7.8%) had severe anxiety. Twenty-two point two percent (22.2%; N=274) of the participants reported moderate symptoms of depression while 10.1% (N=125) had moderately severe symptoms and 6.6% (N=81) could be diagnosed with severe depression. A greater likelihood of screening for depression diagnosis was associated with ages between 25 and 34 years (OR=0.90, 95%CI=0.86-0.94, P<.001), 35 and 44 years (OR=0.88, 95%CI=0.84-0.93, P<.001), and 45 and 54 years (OR=0.87, 95%CI=0.82-0.92, P<.001). Also, a tendency was observed for women to be more prone to high levels of anxiety (OR=1.21, 95%CI=1.08-1.35, P< .001) and depression (OR=2.16, 95%CI=1.51-308, P< .005). Regarding the high prevalence of depression and anxiety, especially in women, appropriate measures for the risk categories should be applied. In the new social context created by the COVID-19 pandemic, screening for psychiatric and psychological disorders should be performed by telemedicine.
- 9 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31331
Open AccessThe Effects of the COVID-19 Pandemic on Mental Health: A Web-Based Study Among Romanian Adults
In Romania, as in other parts of the world, the family doctor is the first to make contact with a healthy patient and is also the first to notice even the smallest pathological changes. In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the patient's communication with the family doctor became even closer and some behavioral changes could be easily noticed. To assess the symptoms of anxiety and depression in the Romanian population using social media platforms in the context of the COVID-19 pandemic. We conducted an anonymous, web-based cross-sectional survey consisting of 31 questions related to general characteristics (age, gender, education, inhabitancy, residence, smoking status, and alcohol consumption) and adapted GAD-7 (7-item General Anxiety Disorders questionnaire) and PHQ-9 (9-item Patient Health Questionnaire). This questionnaire was sent to volunteers in an electronic format through a social network (Facebook, Twitter). The data collected were statistically processed using IBM SPSS v25.0 (IBM Corp., Armonk, NY). The inclusion criteria were age over 18 years and no history of chronic disease. The exclusion criteria consisted of the absence of a mental illness diagnosis. From the 1254 respondents, 1232 cases were selected for statistical analysis after applying the exclusion criteria. The mean age was 35.94 (SD = 11.4, 95%CI=10.9-11.9) with a minimum of 18 years and a maximum of 97 years. Eighty-four point nine percent (84.9%; N=1046) of all study participants are female and 79.13% (N= 975) live in the urban area. A total of 188 (15.25%) were diagnosed with COVID-19 of which 31 (16.66%) were male and 157 (15%) were female. N=170 (13.8%) reported moderate symptoms of anxiety during the last two weeks before the survey while N=96 (7.8%) had severe anxiety. Twenty-two point two percent (22.2%; N=274) of the participants reported moderate symptoms of depression while 10.1% (N=125) had moderately severe symptoms and 6.6% (N=81) could be diagnosed with severe depression. A greater likelihood of screening for depression diagnosis was associated with ages between 25 and 34 years (OR=0.90, 95%CI=0.86-0.94, P<.001), 35 and 44 years (OR=0.88, 95%CI=0.84-0.93, P<.001), and 45 and 54 years (OR=0.87, 95%CI=0.82-0.92, P<.001). Also, a tendency was observed for women to be more prone to high levels of anxiety (OR=1.21, 95%CI=1.08-1.35, P< .001) and depression (OR=2.16, 95%CI=1.51-308, P< .005). Regarding the high prevalence of depression and anxiety, especially in women, appropriate measures for the risk categories should be applied. In the new social context created by the COVID-19 pandemic, screening for psychiatric and psychological disorders should be performed by telemedicine.
- Open Access
- 18 December 2020
- Published by Springer Nature
The effects of the COVID-19 pandemic on mental health
- 18 December 2020
- Published by Springer Nature
Open AccessThe effects of the COVID-19 pandemic on mental health